[Federal Register Volume 62, Number 73 (Wednesday, April 16, 1997)]
[Notices]
[Pages 18631-18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-9733]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made a final finding of scientific misconduct in the 
following case:
    Manoj Misra, Ph.D., Dartmouth College: Based upon the Office of 
Research Integrity's (ORI) review of a report forwarded to ORI by 
Dartmouth

[[Page 18632]]

College, Dr. Misra's admission of certain facts in that report, and 
ORI's own analysis, ORI found that Dr. Misra, a former postdoctoral 
research associate, Department of Chemistry, Dartmouth College, engaged 
in scientific misconduct by intentionally altering laboratory notebook 
data entries for research supported by a grant from the National 
Institute of Environmental Health Sciences (NIEHS), National Institutes 
of Health (NIH).
    Specifically, Dr. Misra altered laboratory notebook data entries in 
two instances in an effort to conceal prior manipulations of that data 
without disclosure or explanation to the principal investigator or 
anyone else. The experiment at issue involved an assay of the chemical 
activity of a carcinogen, and Dr. Misra's change in the readings of the 
``control'' experiment, in which no carcinogen was present, changed the 
results.
    Dr. Misra has accepted the ORI finding and has entered into a 
Voluntary Exclusion Agreement with ORI in which he has voluntarily 
agreed, for the three (3) year period beginning April 7, 1997:
    (1) To exclude himself from serving in any advisory capacity to the 
Public Health Service (PHS), including but not limited to service on 
any PHS advisory committee, board, and/or peer review committee, or as 
a consultant; and
    (2) That any institution that submits an application for PHS 
support for a research project on which Dr. Misra's participation is 
proposed or which uses him in any capacity on PHS supported research 
must concurrently submit a plan for supervision of his duties. The 
supervisory plan must be designed to ensure the scientific integrity of 
Dr. Misra's research contribution. The institution must submit a copy 
of the supervisory plan to ORI.
    No scientific publications were required to be corrected as part of 
this Agreement.

FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research 
Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-9733 Filed 4-15-97; 8:45 am]
BILLING CODE 4160-17-P